| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.6 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.6 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.6 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.6 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.6 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.6 |